Collegium to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Collegium Pharmaceutical (Nasdaq: COLL) has announced its participation in two upcoming investor conferences:

1. The Mizuho Neuro & Ophthalmology Summit 2025, where management will participate in a panel presentation on Wednesday, May 21, 2025, at 11:25 a.m. ET

2. The Jefferies Global Healthcare Conference, featuring a presentation on Thursday, June 5, 2025, at 1:25 p.m. ET. This presentation will be webcast live and accessible through the company's investor relations website, with a replay available for 90 days following the event.

News Market Reaction

+0.44%

1 alert

+0.44% News Effect

On the day this news was published, COLL gained 0.44%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

STOUGHTON, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences:

Mizuho Neuro & Ophthalmology Summit 2025
Panel Presentation: Wednesday, May 21, 2025, at 11:25 a.m. ET

Jefferies Global Healthcare Conference
Presentation: Thursday, June 5, 2025, at 1:25 p.m. ET

The presentation at Jefferies Global Healthcare Conference will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

About Collegium Pharmaceutical, Inc.
Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of responsible pain management medications and recently acquired Jornay PM®, a treatment for ADHD, establishing a presence in neuropsychiatry. Collegium’s strategy includes growing its commercial portfolio, with Jornay PM as the lead growth driver, and deploying capital in a disciplined manner. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Investor Contacts:
Ian Karp
Head of Investor Relations
ir@collegiumpharma.com

Danielle Jesse
Director, Investor Relations
ir@collegiumpharma.com

Media Contact:
Cheryl Wheeler
Head of Corporate Communications
communications@collegiumpharma.com
        

FAQ

When is Collegium Pharmaceutical (COLL) presenting at the Jefferies Global Healthcare Conference 2025?

Collegium Pharmaceutical will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 1:25 p.m. ET.

How can I watch Collegium's (COLL) presentation at the Jefferies Healthcare Conference 2025?

The presentation can be accessed live through the Investors section of Collegium's website at https://ir.collegiumpharma.com. A replay will be available for 90 days after the presentation.

When is Collegium (COLL) participating in the Mizuho Neuro & Ophthalmology Summit 2025?

Collegium will participate in a panel presentation at the Mizuho Neuro & Ophthalmology Summit on Wednesday, May 21, 2025, at 11:25 a.m. ET.

Which investor conferences is Collegium Pharmaceutical (COLL) attending in 2025?

Collegium Pharmaceutical is attending the Mizuho Neuro & Ophthalmology Summit on May 21, 2025, and the Jefferies Global Healthcare Conference on June 5, 2025.